期刊文献+

利奈唑胺致血小板减少3例 被引量:13

Thrombocytopenia induced by linezolid in three patients
原文传递
导出
摘要 3例男性患者,年龄46~91岁,给予利奈唑胺600mg,2次/d静脉滴注治疗感染。给药前血小板计数正常,治疗3~17d后均出现血小板减少。血小板计数分别为95×109/L、74×109/L、86×109/L。停用利奈唑胺,改用亚胺培南-西司他丁钠、万古霉素、美洛培南,其他治疗不变,2~9d后血小板计数恢复正常。 Three male patients,aged 46~91 years,received respectively an IV infusion of linezolid 600 mg twice daily for infections.Their platelet counts were normal before linezolid administration.All of them developed thrombocytopenia after 3~17 days of therapy.Platelet counts were 95×109/L,74×109/L,and 86×109/L,respectively.Linezolid was stopped and switched to imipenem-cilastatin sodium,vancomycin,and meropenem;and other treatments were unchanged.The level of platelet returned to within normal range.
出处 《药物不良反应杂志》 2010年第1期53-54,共2页 Adverse Drug Reactions Journal
关键词 利奈唑胺 不良反应 血小板减少 linezolid adverse reactions thrombocytopenia
  • 相关文献

参考文献6

  • 1Long JK. Agents for the treatment of multidrug-resistant grampositive endocarditis [ J ]. Curr Infect Dis Rep, 2005, 7 (4) : 245-250.
  • 2Stevens DL, Dotter B, Madaras-KeUy K. A review of linezolid : the first oxazolidinone antibiotic [ J ]. Expert Rev Anti Infect Ther, 2004, 2( 1 ) : 51-59.
  • 3Garazzino S, De Rosa FG, Bargiacchi O, et al. Haematological safety of long-term therapy with linezolid[ J]. Int J Antimicrob Agents, 2007, 29(4): 480-483.
  • 4周颖杰.利奈唑胺治疗严重感染建议在治疗复杂患者时监测不良反应[J].中国感染与化疗杂志,2006,6(5):345-345. 被引量:17
  • 5Jeol G, Hardman, Lee E. Limbird. Goodman & Gilmans. The pharmacological basis of therapeutics [ M ]. 10th ed. New York: MeGraw Hill, 2001:1260.
  • 6Attassi K, Hershberger E, Alam R, et al. Thrombocytopenia associated with linezolid therapy [ J]. Clin Infect Dis, 2002, 34(5) : 695-698.

共引文献16

同被引文献129

  • 1张俊忠.美罗培南诱发严重血小板减少症1例[J].药物流行病学杂志,2004,13(6):350-350. 被引量:15
  • 2张国荣,王少峰,范秀芳,徐强(编校).早产儿凝血功能特点及其与出血的关系[J].中国妇幼保健,2007,22(5):607-608. 被引量:14
  • 3Zabransky RJ.Linezolid:the first of a new class of antimicrobial agents[J].Clin Microb Newslett,2002,24(4):25-30.
  • 4Gerson SL,Kaplan SL,Bruss JB,et al.Hematologic effects of linezolid:summary of clinical experience[J].Antimicrob Agents Chemother,2002,46(8):2723-2726.
  • 5Nasraway SA,Shorr AF,Kuter D J,et al.Linezolid does not increase the risk of thromboeytopenia in patients with nosocomial pneumonia:comparative analysis of linezolid and vancomycin use[J].Clin Infect Dis,2003,37(12):1609-1616.
  • 6Rao N,Ziran BH,Wagener MM,et al.Similar hematologic effects of long-term linezolid and vancomyein therapy in a prospective observational study of patients with orthopedic infections[J].Clin Infect Dis,2004,38(8):1058-1004.
  • 7Grau S,Morales-Molina JA,Mateu-de Antonio J,et al.Linezolid:low pre-treatment platelet values could increase the risk of thrombocytopenia[J].J Antimicrob Chemother,2005,56(2):440-441.
  • 8Grim SA,Rene L,Gupta S,et al.Safety of linezolid in patients with baseline thrombocytopenia[J].J Antimicrob Chemother,2008,62(4):850-851.
  • 9Rubinstein E,Isturiz R,Standiford HC,et al.Worldwide assessment of linezolid's clinical safety and tolerability:comparator-controlled phase Ⅲ studies[J].Antimicrob Agents Chemother,2003,47(6):1824-1831.
  • 10Birmingham MC,Rayner CR,Meagher AK,et al.Linezolid for the treatment of muhidrug-resistant,Grampositive infections:experience from a compassionate-use program[J].Clin Infect Dis,2003,36(2):159-168.

引证文献13

二级引证文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部